Zobrazeno 1 - 10
of 115
pro vyhledávání: '"RYO SHIBATA"'
Autor:
Ryo Shibata
Publikováno v:
IEEE Access, Vol 12, Pp 125384-125397 (2024)
Error-correcting codes for insertion and deletion (ID) errors have attracted considerable attention because of their potential in future communication and storage systems. Existing schemes based on modern coding approaches approach the information-th
Externí odkaz:
https://doaj.org/article/c50cccb4003c454f9217e14af9a503e0
Autor:
Shusuke Hagihara, Hideki Ohta, Jun Tanaka, Teruaki Shiokawa, Yoshikuni Kida, Yohei Iguchi, Masato Tatsumi, Ryo Shibata, Kenichi Tahara, Tatsuya Shibata, Kyoichi Sanada, Takuaki Ymamoto
Publikováno v:
Asian Spine Journal, Vol 17, Iss 5, Pp 818-825 (2023)
Study Design This study adopted a retrospective cohort study design. Purpose This study aimed to clarify the influence of diffuse idiopathic skeletal hyperostosis (DISH) on bone fusion after transforaminal lumbar interbody fusion (TLIF). Overview of
Externí odkaz:
https://doaj.org/article/4703d5511d6343c2a9a008fe7dc23974
Autor:
Yuka Kurokawa, Yusuke Kaida, Takuma Hazama, Yosuke Nakayama, Takaomi Otome, Ryo Shibata, Sakuya Ito, Goh Kodama, Nao Nakamura, Takatoshi Kambe, Tomofumi Moriyama, Akiko Nagata, Aki Minami, Ryotaro Ando, Yoshifumi Wada, Miki Sugiyama, Michiaki Usui, Michio Chiba, Atsuo Moriyama, Atsuko Ohara, Hiroshi Miyazaki, Tatsuyuki Kakuma, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalc
Externí odkaz:
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Yusuke Kaida, Takatoshi Kambe, Shintaro Kishimoto, Yusuke Koteda, Kenji Suda, Ryo Yamamoto, Tetsurou Imai, Takuma Hazama, Yoshimi Takamiya, Ryo Shibata, Hidemi Nishida, Seiya Okuda, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the
Externí odkaz:
https://doaj.org/article/bf3e01053b684b33ab0230e39e5a87ce
Autor:
Miki Sugiyama, Takuma Hazama, Kaoru Nakano, Kengo Urae, Tomofumi Moriyama, Takuya Ariyoshi, Yuka Kurokawa, Goh Kodama, Yoshifumi Wada, Junko Yano, Yoshihiko Otsubo, Ryuji Iwatani, Yukie Kinoshita, Yusuke Kaida, Makoto Nasu, Ryo Shibata, Kyoko Tashiro, Kei Fukami
Publikováno v:
Nutrients, Vol 13, Iss 6, p 1900 (2021)
L-carnitine (LC) supplementation improves cardiac function in hemodialysis (HD) patients. However, whether reducing LC supplementation affects carnitine kinetics and cardiac function in HD patients treated with LC remains unclear. Fifty-nine HD patie
Externí odkaz:
https://doaj.org/article/c935c1b22cd8430a9c36f78ff506ed2f
Autor:
Ryo Shibata, Hiroyuki Yashima
Publikováno v:
IEEE Transactions on Magnetics. 59:1-9
Autor:
Ryo Shibata, Hiroyuki Yashima
Publikováno v:
IEICE Communications Express. 11:697-702
Autor:
RYO SHIBATA, JINYA TAKAHASHI, HIROMI SATO, MUNEHISA BEKKI, KODAI SHIBAO, HIDEYA SATO, SHOICHIRO NOHARA, AKIHIRO HONDA, NAOKI ITAYA, HIDETOSHI CHIBANA, YOSHIHIRO FUKUMOTO
Publikováno v:
The Kurume Medical Journal.
Autor:
HIROMI SATO, JINYA TAKAHASHI, MUNEHISA BEKKI, RYO SHIBATA, KODAI SHIBAO, HIDEYA SATO, SHOICHIRO NOHARA, AKIHIRO HONDA, NAOKI ITAYA, HIDETOSHI CHIBANA, YOSHIHIRO FUKUMOTO
Publikováno v:
The Kurume Medical Journal.
Publikováno v:
IEICE Communications Express. 11:111-116